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Abstract
Many studies have reported inverse associations between
vegetable and fruit consumption and lung cancer risk.
The aim of the present study was to elucidate the role of
several antioxidants and folate in this relationship. In the
Netherlands Cohort Study on Diet and Cancer, 58,279
men of ages 55–69 years at baseline in 1986 returned a
questionnaire including a 150-item food frequency
questionnaire. After 6.3 years of follow-up, 939 male lung
cancer cases were registered. A new Dutch carotenoid
database was used to estimate intake of a-carotene, b-
carotene, lutein 1 zeaxanthin, b-cryptoxanthin, and
lycopene, completed with the antioxidant vitamins C and
E and folate. Using case-cohort analysis, rate ratios were
calculated, adjusted for age, smoking, educational level,
and family history of lung cancer. Protective effects on
lung cancer incidence were found for lutein 1
zeaxanthin, b-cryptoxanthin, folate, and vitamin C. Other
carotenoids (a-carotene, b-carotene, and lycopene) and
vitamin E did not show significant associations. After
adjustment for vitamin C, only folate remained inversely
associated, and after adjustment for folate, only b-
cryptoxanthin and vitamin C remained significantly
associated. Inverse associations were strongest among
current smokers and weaker for former smokers at
baseline. Inverse associations with carotenes, lutein 1
zeaxanthin, and b-cryptoxanthin seemed to be limited to
small cell and squamous cell carcinomas. Only folate and
vitamin C intake appeared to be inversely related to
small cell and squamous cell carcinomas and
adenocarcinomas. Folate, vitamin C, and b-cryptoxanthin
might be better protective agents against lung cancer in
smokers than a-carotene, b-carotene, lutein 1
zeaxanthin, and lycopene.
Introduction
Vegetables and fruits are associated with a reduced risk of
cancers, especially lung cancer (1–4). Recent results from the
Netherlands Cohort Study on Diet and Cancer on vegetable and
fruit consumption and the association with cancer incidence at
several sites have revealed reduced risks for lung cancer (5),
less pronounced effects on colorectal cancer (6) and stomach
cancer (7), and no effect on prostate cancer (8).
The possible protective compounds in vegetables and fruit
include a wide variety of phytochemicals (9). Among them are
the carotenoids, colorful compounds that are abundant as pig-
ments in plants. The main carotenoids are a-carotene, b-caro-
tene, lutein, zeaxanthin, b-cryptoxanthin, and lycopene. They
are potent quenchers of free radicals, which are by-products of
metabolic processes originating from environmental pollutants
such as cigarette smoke. Some carotenoids can be metabolically
converted into retinol (a-carotene, b-carotene, and b-cryptox-
anthin). Case-control studies on the relationship between caro-
tenoids in food and the incidence of lung cancer have shown
inverse associations with b-carotene, a-carotene, and lutein 1
zeaxanthin but not with lycopene or b-cryptoxanthin (10, 11).
In the past decade, eight prospective studies have been pub-
lished concerning the association of dietary carotenoids and
other antioxidants with lung cancer risk (12–19). Six of them
presented RRs3 using a summed variable for carotenoids (12,
14, 15, 17–19); one of them also presented mean daily intakes
for the major carotenoids for cases and non-cases (12). Four
studies presented RRs separately for b-carotene (13–16), and
one recent study presented RRs for all major carotenoids (19).
In the analyses, other antioxidants were included such as vita-
min E (12, 16–19) and vitamin C (12–19), and two studies
included folate (18, 19). The studies were performed in men
(12, 14, 16), women (15, 19), or both (13, 17, 18). Most studies
presented RRs for the respective food constituents by smoking
status (12, 15, 17, 18) and/or by histological type of lung cancer
(15, 18).
We have recently developed a database containing data on
the most important carotenoids based on chemical analyses of
the main vegetables and literature values (20). This gave us the
opportunity to perform analyses on lung cancer incidence and
carotenoid intake in the Netherlands Cohort Study on Diet and
Cancer and to evaluate in more detail possible mechanisms
underlying the inverse associations found between vegetable
and fruit consumption and the incidence of lung cancer (6). In
addition to the carotenoids covered by the database (a-carotene,
b-carotene, lutein 1 zeaxanthin, b-cryptoxanthin, and lyco-
pene), folate and the antioxidant vitamins C and E were in-
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cluded in the analyses. With over 900 incident male lung cancer
cases, analyses could be performed for separate strata of smok-
ing status and histology.
Materials and Methods
Subjects. The Netherlands Cohort Study on diet and cancer is
a prospective cohort study that started in September 1986. The
study design has been reported in detail elsewhere (21). The
cohort included 58,279 men of ages 55–69 years at the begin-
ning of the study. The study population originated from 204
municipalities with computerized population registries.
Data Collection. At baseline, the cohort members completed a
mailed, self-administered questionnaire on dietary habits, life-
style, smoking, personal and family history of cancer, and
demographics. The dietary section of the questionnaire was a
150-item semiquantitative food frequency questionnaire. The
questionnaire concentrated on the habitual consumption of
foods and beverages during the year preceding the start of the
study. The principal nutrients of interest in the design of the
questionnaire were energy, protein, fat, cholesterol, carbohy-
drates, dietary fiber, alcohol, calcium, vitamin A, b-carotene,
and vitamin C. The questionnaire was validated against a 9-day
diet record (22).
Information on dietary supplement use was collected with
an open-ended question with space for four different supple-
ments at most. Participants were asked whether they used
vitamin tablets, drops, or other preparations during the 5 years
before baseline.
Food Composition Tables. Mean daily nutrient intakes were
calculated using the computerized Dutch food composition
table (23). For calculation of the intake of specific carotenoids,
an additional food composition table has been constructed
recently (20), providing information on the most important
carotenoids: a- carotene, b-carotene, lutein 1 zeaxanthin, ly-
copene, and b-cryptoxanthin. Briefly, foods that are the main
sources of carotenoids (e.g., vegetables) were sampled and
analyzed for a-carotene, b-carotene, lutein, zeaxanthin, and
lycopene. Some other foods, such as margarines, were also
analyzed to check data supplied by manufacturers. Values for
all other foods mostly were derived from recent literature based
on the same methods of analysis as we used. For mixed dishes,
carotenoids were estimated based on the recipe of preparation.
Vegetables were sampled in two to three periods across a year,
and at each occasion a pooled sample derived from seven
different retailers was analyzed as described previously (20). In
the carotenoid food composition table, lutein and zeaxanthin
had to be taken together because most of the literature sources
used did not provide separate values for each of these carote-
noids. Vegetables, however, contain primarily lutein and only
minor quantities of zeaxanthin. Folate content was mainly de-
rived from the food composition tables of McCance and Wid-
dowson (24).
Record Linkage. The method of record linkage to obtain
information on cancer incidence has been described previously
(25). In short, follow-up for incident cancer was established by
computerized record linkage with all regional cancer registries
in the Netherlands and with PALGA, a computerized national
database of pathology reports. Completeness of follow-up of
cancer was at least 96% (26). After 6.3 years of follow-up, i.e.,
from September 1986 to December 1992, 1096 incident male
lung cancer cases were identified.
Data Analysis. The case-cohort approach was used for data
analysis (27). This means that cases are enumerated for the
entire cohort, whereas the person-years at risk for the entire
cohort are estimated from a random subcohort sample. After
baseline exposure measurement, a subcohort of 1688 men was
randomly sampled from the cohort and followed up biennially
for vital status information. No subcohort members were lost to
follow-up over the 6.3 years of follow-up.
After exclusion of lung cancer cases who reported prev-
alent cancer other than skin cancer at baseline, lung cancer
cases without microscopically confirmed cancer, cases with
lung cancer other than carcinoma (sarcoma, lymphoma, and
unspecified morphology), or with in situ lung carcinoma, 1050
incident lung cancer cases were identified. From the subcohort,
prevalent cancer cases other than skin cancer were excluded as
well. Subjects with incomplete or inconsistent dietary data were
also excluded from analyses. These included subjects who: (a)
left blank 60 (of 150) items in the questionnaire and reported to
eat ,35 items at least once a month or more; or (b) subjects
who left one or more item blocks (grouping of items, e.g.,
beverages) blank. More details are given in a separate report
(22). Eventually, 939 male lung cancer cases and 1525 male
subcohort members were available for analyses.
Analyses were performed for the carotenoids a-carotene,
b-carotene, lutein 1 zeaxanthin, lycopene, and b-cryptoxan-
thin, vitamin C, vitamin E, and folate. Mean intakes and SDs
were calculated for cases and subcohort members. For different
strata of age, smoking status, educational level, and family
history of lung cancer, mean intakes were calculated for the
subcohort. Pearson correlation coefficients were calculated for
the food constituents of interest and energy intake. RRs of lung
cancer and their 95% CIs were computed using the GLIM
statistical package (28). Exponentially distributed survival
times were assumed in the follow-up period. Because standard
software was not available for case-cohort analysis, specific
macros were developed to account for the additional variance
introduced by sampling from the cohort instead of using the
entire cohort (29). Age, level of education, family history of
lung cancer, current cigarette smoking (yes/no), number of
cigarettes per day, and years of smoking cigarettes were con-
sidered as potential confounders for which the RRs were ad-
justed. Because energy consumption is frequently considered to
confound RRs, an additional model was used that included
energy. Additionally, models were used adjusting for either
vitamin C or folate content, because these nutrients were found
to be highly correlated to (some of the) carotenoids. Tests for
trends in the RRs were based on two-sided likelihood ratio
tests. Intakes of food constituents were classified into quintiles
based on the distribution in the subcohort. For vitamin C,
however, the validation study had pointed out that quintiles 2
and 3 and quintiles 4 and 5 could not be distinguished; there-
fore, we reduced vitamin C intake to three categories (22). RRs
for quintiles/categories of intake were also computed separately
in never-smokers, former smokers, and current smokers. Be-
cause the number of cases among never-smokers was small,
tertiles of intake were used instead of quintiles. Also, subgroup
analyses were performed for the most common histological
types of lung cancer: small cell carcinoma, squamous cell
carcinoma, and adenocarcinoma.
Results
For both lung cancer cases and subcohort members, mean daily
intakes of the major carotenoids, vitamin C, vitamin E, and
folate are presented in Table 1. In general, intakes were lower
among cases than in the subcohort. Mean daily intakes of the
subcohort are presented for different categories of age, smoking
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status, educational level, and family history of lung cancer,
which are potential confounders of the association between
intake data and lung cancer incidence (Table 2). In the higher
age categories, intake of carotenes and folate tended to be lower
and intakes of b-cryptoxanthin and vitamin C tended to be
higher (Table 2). Current smokers had the lowest intakes for all
carotenoids and vitamins of interest, and subjects who had
never smoked had the highest intakes (except for vitamin E).
For educational level, intake data did not show clear trends, and
subjects with a family history of lung cancer tended to have
lower intakes of most carotenoids and vitamins of interest.
Because the carotenoids and vitamins partly originated
from the same food sources (vegetables and fruit), intakes could
be highly correlated. To illustrate this, Pearson correlation
coefficients were calculated for subcohort members (Table 3).
Correlations were high between a-carotene and b-carotene
(0.93), between lutein 1 zeaxanthin and b-carotene (0.68),
between vitamin C and b-cryptoxanthin (0.77), and between
folate and either b-carotene (0.62), lutein 1 zeaxanthin (0.66),
or vitamin C (0.66). Also, correlation coefficients with energy
intake were generally low with the exception of vitamin E
(0.53) and folate (0.58).
RRs for lung cancer were calculated with different models.
The most straightforward model, including age, smoking, so-
cioeconomic status, and family history of lung cancer, revealed
significant inverse associations with lung cancer incidence for
lutein 1 zeaxanthin, b-cryptoxanthin, vitamin C, and folate
(RRs for highest versus lowest category: 0.72, 0.71, 0.63, and
0.70, respectively; 95% CI all excluding 1.00; and P-trends
,0.05; Table 4). No significant effects were found for a-
carotene, b-carotene, lycopene, or vitamin E, although for the
carotenes RRs were ,1.00 for all quintiles above reference.
The use of supplements containing vitamin C or vitamin E was
not associated with the incidence of lung cancer. Including
energy intake in the model did not change RRs importantly.
Additional inclusion of vitamin C, however, reduced the effects
found previously, leaving only folate with a significant negative
trend. Adjustment for folate only left significant negative as-
sociations for b-cryptoxanthin and vitamin C.
Cases and subcohort members were classified based on
smoking status at baseline: never-smokers (35 cases), former
smokers (312 cases), and current smokers (487 cases; Table 5).
In current smokers, significant inverse associations were found
for b-carotene, lutein 1 zeaxanthin, b-cryptoxanthin, vitamin
C, and folate, and the associations were stronger than those
found in unstratified analyses. In former smokers, significant
inverse trends were found only for lutein 1 zeaxanthin; all
other RRs were closer to 1.00 than for current smokers. How-
ever, RR estimates for the carotenes, folate, and vitamin C
remained ,1.00 for all quintiles/categories above reference.
With only 35 lung cancer cases among never-smokers, esti-
mates were unstable, despite the use of tertiles of intake instead
of quintiles. No significant trends were found for the carote-
noids and vitamins of interest. For b-cryptoxanthin, vitamin C,
and vitamin E, estimates were ,1.00 for all categories of intake
above reference, and for the carotenes, they were .1.00. In
analogy with data presented in Table 4, additional adjustments
were made for either vitamin C or folate (results not shown).
For current smokers, inverse relationships with both carotenes
and lutein/zeaxanthin disappeared, whereas negative associa-
tions with b-cryptoxanthin, vitamin C, and folate remained
intact. Additional adjustment for vitamin C or folate left the
negative associations with lutein/zeaxanthin and folate in for-
mer smokers unchanged. In never-smokers, additional adjust-
ment for either vitamin C or folate resulted in a stronger
positive association with b-carotene (results not shown).
Lutein 1 zeaxanthin, b-cryptoxanthin, vitamin C, and
folate showed significant inverse associations with both risk of
small cell carcinomas (157 cases) and squamous cell carcino-
mas (377 cases; Table 6). Nonsignificant inverse associations
were found for a-carotene and b-carotene with small cell
carcinomas. Adenocarcinomas (143 cases) seemed to be in-
versely associated only with folate intake and (borderline) with
vitamin C but not with the carotenoids. Similar to analyses for
all lung cancer cases taken together, additional adjustment for
vitamin C resulted in a loss of inverse associations with lutein
1 zeaxanthin and b-cryptoxanthin, with the exception of
b-cryptoxanthin in squamous cell carcinomas, which stayed
significantly negative. The inverse association with folate dis-
appeared for small cell carcinomas but not squamous cell and
adenocarcinomas. Similar to analyses for the whole group,
adjustment for folate weakened the inverse associations for
small and squamous cell carcinomas with lutein 1 zeaxanthin
but not with b-cryptoxanthin. The inverse associations found
with vitamin C were weaker for all histological types of car-
cinomas after adjustment for folate. b-Carotene turned out to
have a significant positive relationship with adenocarcinomas
(results not shown).
Because folate and vitamin C were highly correlated,
additional analyses were performed with combinations of ter-
tiles of folate consumption with categories of vitamin C intake
(Table 7). For men who had high intake of both nutrients
compared with men who had a low intake, the RR was 0.56
(95% CI, 0.44–0.72). In the highest tertile of folate intake, a
higher vitamin C intake led to a lower RR, and vice versa.
Discussion
In the Netherlands Cohort Study on Diet and Cancer, the
associations were evaluated between lung cancer incidence and
intakes of several carotenoids, vitamin C, vitamin E, and folate.
After adjustment for age, smoking history, education level, and
family history of lung cancer, statistically significant protective
effects on lung cancer incidence were found for the carotenoids
lutein 1 zeaxanthin and b-cryptoxanthin as well as for folate
and vitamin C. For other carotenoids (a-carotene, b-carotene,
and lycopene) and vitamin E, no such inverse associations were
found. Use of supplements containing vitamin C or vitamin E
did not influence lung cancer incidence. In our previous report
on vegetable and fruit consumption and lung cancer risk, con-
sumption of vegetables and fruits appeared to be inversely
associated with lung cancer (5). The protective effect on lung
Table 1 Daily intake of carotenoids, vitamins C and E, and folate in male
lung cancer cases and subcohort members: Netherlands Cohort Study
1986–1992
Unit Cases
a
(n 5 939)
Subcohorta
(n 5 1525)
a-Carotene mg/day 644 (486) 691 (555)
b-Carotene mg/day 2813 (1383) 2976 (1555)
Lutein 1 Zeaxanthin mg/day 2455 (1152) 2554 (1149)
b-Cryptoxanthin mg/day 138 (159) 152 (160)
Lycopene mg/day 983 (1517) 1050 (1560)
Vitamin C mg/day 92 (42) 98 (42)
Vitamin E mg/day 14.4 (6.4) 14.7 (6.6)
Folate mg/day 291 (82) 303 (80)
Vitamin C supplement use % yes 6.3% 8.2%
Vitamin E supplement use % yes 4.3% 4.8%
a Mean (SD).
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cancer was not limited to a specific group of vegetables or
fruits, but the effect was strongest for vegetables of the Brassica
genus and for citrus fruit. The present analyses on carotenoids,
other antioxidants, and folate suggest that neither a-carotene
nor b-carotene is mainly responsible for the inverse associa-
tions found, but that contributions of lutein 1 zeaxanthin,
b-cryptoxanthin, folate, and vitamin C are more important. The
RRs for these food constituents, comparing the highest category
of intake with the lowest one, are of the same magnitude as the
ones found for vegetable and fruit intake. The relatively low RR
for vitamin C (0.63; 95% CI, 0.49–0.83) is in line with the
lower RRs for oranges and fresh orange juice, as published
before.
There may be some limitations to this study which could
have influenced the results. With 6.3 years of follow-up and
939 male lung cancer cases, the power of the study is such that
the probability for overall observed results to be caused by
chance is small. The prospective nature of a cohort study
together with completeness of follow-up, as has been achieved
in this study, reduced the potential for selection bias to a
minimum. Information bias, i.e., a change in (reported) dietary
habits of lung cancer cases because of the disease, is also
largely avoided in a prospective study because dietary habits
were reported before the disease was diagnosed. A change in
dietary habits of subjects with latent lung cancer at the time of
completing the baseline questionnaire remains, however, a pos-
sibility, although this is much less likely than in subjects with
gastrointestinal cancer, for example. Repeating analyses ex-
cluding cases diagnosed during the first year of follow-up
hardly affected RRs (results not presented).
Intake data were based on the baseline questionnaire in
1986, departing from the assumption that dietary and other
habits would not change considerably during the 6.3 years of
follow-up. Because participants were 55–70 years of age at
entry, important changes were not expected. In a random sam-
ple of the cohort, the reproducibility of the questionnaire was
tested during the first 5 years of follow-up, which led to the
conclusion that the potential of a single food frequency ques-
tionnaire measurement to rank subjects according to nutrient
intake dropped only slightly over time (30). Measurement error
attributable to use of the carotenoid database will be relatively
small, because analyses were performed in those vegetables
known to be mainly responsible for carotenoid intake in the
Dutch diet.
A potentially more realistic threat to the interpretation of
the observed inverse associations is residual confounding by
risk factors for lung cancer that happen to be associated with the
intake of carotenoids, vitamin C, vitamin E, or folate. The most
important risk factor in this respect is cigarette smoking. Un-
healthy habits, such as smoking and a diet low in vegetables and
fruit, tend to cluster in the same subjects in most populations
(31); therefore, insufficient control of one factor will confound
the association between the other factor and lung cancer. In this
way, it might happen that an observed inverse association
between intake of food constituents and lung cancer was at-
tributable to residual confounding by smoking. Evidence of an
Table 2 Mean dietary intake of carotenoids, vitamins C and E, and folate for several characteristics in the subcohort (n 5 1525): Netherlands Cohort Study
1986–1992
n
a-Carotenea
mg/day
b-Carotenea
mg/day
Lutein 1 Zeaxanthina
mg/day
b-Cryptoxanthina
mg/day
Lycopenea
mg/day
Vitamin Ca
mg/day
Vitamin Ea
mg/day
Folatea
mg/day
Age (yr)
55–59 582 713 (595) 3037 (1625) 2576 (1105) 140 (149) 992 (1171) 95 (40) 14.8 (6.9) 307 (83)
60–64 534 689 (544) 2972 (1561) 2536 (1155) 152 (161) 1167 (2063) 98 (41) 14.9 (6.6) 303 (79)
65–69 409 663 (507) 2896 (1440) 2546 (1204) 170 (173) 979 (1244) 102 (44) 14.2 (6.3) 296 (77)
Smoking status
Never 204 823 (711) 3264 (1936) 2581 (1225) 173 (164) 1135 (1492) 103 (43) 14.7 (6.6) 312 (88)
Former smoker 778 694 (555) 2991 (1541) 2568 (1114) 154 (162) 1073 (1723) 100 (42) 14.9 (6.6) 305 (79)
Current smoker 543 639 (476) 2847 (1393) 2525 (1171) 141 (156) 985 (1320) 94 (41) 14.3 (6.7) 296 (77)
Highest educational levelb
Primary school 393 699 (583) 2997 (1722) 2581 (1323) 133 (164) 938 (1490) 92 (43) 14.2 (6.2) 299 (86)
Lower vocational 321 687 (483) 2960 (1446) 2571 (1192) 140 (137) 938 (1323) 96 (41) 15.6 (7.1) 311 (84)
Secondary/medium vocational 530 684 (607) 2964 (1600) 2571 (1104) 170 (170) 1093 (1780) 103 (43) 14.7 (6.5) 303 (78)
University/higher vocational 271 707 (481) 3006 (1328) 2464 (900) 159 (159) 1256 (1442) 101 (39) 14.3 (6.7) 299 (69)
Family history of lung cancer
No 138 696 (566) 2984 (1557) 2550 (1124) 151 (159) 1052 (1580) 98 (42) 14.7 (6.7) 303 (79)
Yes 141 648 (431) 2896 (1537) 2590 (1379) 161 (169) 1025 (1351) 97 (42) 14.2 (5.9) 300 (87)
a Mean (SD).
b Totals do not add to 1525 because of missing values.
Table 3 Pearson correlation coefficients of carotenoids, other antioxidant vitamins, and folate in men from the subcohort of the Netherlands Cohort Study
1986–1992
a-Carotene b-Carotene Lutein/Zeaxanthin b-Cryptoxanthin Lycopene Vitamin C Vitamin E Folate Energy
a-Carotene 0.93 0.39 0.13 0.16 0.30 0.16 0.44 0.24
b-Carotene 0.68 0.16 0.26 0.42 0.23 0.62 0.31
Lutein/Zeaxanthin 0.17 0.15 0.47 0.22 0.66 0.22
b-Cryptoxanthin 0.08 0.77 0.07 0.34 0.05
Lycopene 0.23 0.11 0.20 0.06
Vitamin C 0.23 0.66 0.23
Vitamin E 0.42 0.53
Folate 0.58
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Table 4 RRsa (95% CI) for quintiles of dietary intake of carotenoids, vitamins C and E, and folate for lung cancer, according to different models: Netherlands
Cohort Study 1986–1992
Median Age, family history,
smoking, SESb
Age, family history,
smoking, SES, energy
Age, family history, smoking,
SES, vit C (catb), energy (contb)
Age, family history, smoking,
SES, folate (quintiles),
energy (cont)
a-Carotene mg/day
Quintile 1c 198 1.00 1.00 1.00 1.00
Quintile 2 378 0.60 (0.44–0.82) 0.60 (0.44–0.83) 0.63 (0.45–0.87) 0.63 (0.46–0.88)
Quintile 3 565 0.69 (0.51–0.95) 0.70 (0.51–0.96) 0.74 (0.53–1.02) 0.88 (0.57–1.09)
Quintile 4 809 0.83 (0.61–1.13) 0.85 (0.62–1.15) 0.90 (0.66–1.24) 0.96 (0.69–1.32)
Quintile 5 1300 0.85 (0.62–1.16) 0.89 (0.65–1.23) 1.01 (0.71–1.43) 1.00 (0.71–1.40)
P-trend 0.77 0.90 0.29 0.20
b-Carotene mg/day
Quintile 1c 1480 1.00 1.00 1.00 1.00
Quintile 2 2148 0.72 (0.53–0.98) 0.73 (0.54–1.00) 0.79 (0.57–1.09) 0.83 (0.60–1.14)
Quintile 3 2675 0.79 (0.58–1.09) 0.81 (0.59–1.12) 0.90 (0.64–1.27) 1.00 (0.72–1.39)
Quintile 4 3351 0.83 (0.61–1.13) 0.86 (0.63–1.18) 0.99 (0.68–1.45) 1.14 (0.80–1.62)
Quintile 5 4729 0.81 (0.59–1.11) 0.85 (0.63–1.18) 1.02 (0.68–1.53) 1.11 (0.76–1.60)
P-trend 0.21 0.48 0.38 0.09
Lutein/Zeaxanthin mg/day
Quintile 1c 1388 1.00 1.00 1.00 1.00
Quintile 2 1897 0.78 (0.57–1.06) 0.78 (0.58–1.06) 0.81 (0.59–1.12) 0.87 (0.64–1.19)
Quintile 3 2376 0.71 (0.52–0.97) 0.72 (0.53–0.99) 0.81 (0.56–1.17) 0.85 (0.61–1.18)
Quintile 4 2853 0.72 (0.53–0.99) 0.74 (0.54–1.01) 0.86 (0.57–1.29) 0.97 (0.68–1.39)
Quintile 5 3857 0.72 (0.53–0.99) 0.75 (0.54–1.03) 0.88 (0.57–1.38) 0.96 (0.65–1.43)
P-trend 0.001 0.005 0.39 0.91
b-Cryptoxantin mg/day
Quintile 1c 12 1.00 1.00 1.00 1.00
Quintile 2 46 0.77 (0.57–1.04) 0.78 (0.58–1.06) 0.84 (0.61–1.15) 0.79 (0.58–1.07)
Quintile 3 103 0.64 (0.47–0.87) 0.64 (0.47–0.88) 0.73 (0.50–1.05) 0.68 (0.49–0.93)
Quintile 4 194 0.64 (0.47–0.88) 0.66 (0.48–0.88) 0.80 (0.49–1.30) 0.72 (0.52–1.00)
Quintile 5 356 0.71 (0.52–0.96) 0.72 (0.53–0.98) 0.91 (0.33–1.74) 0.82 (0.59–1.13)
P-trend ,0.0001 0.0002 0.22 0.02
Lycopene mg/day
Quintile 1c 132 1.00 1.00 1.00 1.00
Quintile 2 251 0.82 (0.60–1.12) 0.83 (0.61–1.23) 0.85 (0.62–1.17) 0.87 (0.63–1.19)
Quintile 3 720 1.01 (0.74–1.38) 1.02 (0.75–1.39) 1.14 (0.82–1.57) 1.09 (0.79–1.49)
Quintile 4 1087 1.07 (0.79–1.47) 1.07 (0.79–1.47) 1.21 (0.87–1.69) 1.18 (0.85–1.62)
Quintile 5 2035 0.91 (0.67–1.25) 0.93 (0.67–1.27) 1.12 (0.77–1.61) 1.05 (0.75–1.46)
P-trend 0.81 0.72 0.04 0.14
Vitamin Cd mg/day
Category 1c 51 1.00 1.00 1.00
Category 2 82 0.69 (0.53–0.90) 0.70 (0.59–0.83) 0.79 (0.59–1.05)
Category 3 138 0.63 (0.49–0.83) 0.64 (0.54–0.77) 0.77 (0.54–1.08)
P-trend ,0.0001 ,0.0001 0.03
Vitamin E mg/day
Quintile 1c 7 1.00 1.00 1.00 1.00
Quintile 2 10 1.19 (0.87–1.63) 1.23 (0.90–1.69) 1.31 (0.93–1.83) 1.34 (0.98–1.85)
Quintile 3 13 1.13 (0.83–1.55) 1.21 (0.88–1.67) 1.25 (0.90–1.74) 1.31 (0.94–1.82)
Quintile 4 17 1.01 (0.74–1.38) 1.08 (0.78–1.51) 1.14 (0.81–1.62) 1.16 (0.83–1.64)
Quintile 5 24 1.02 (0.74–1.41) 1.15 (0.80–1.65) 1.21 (0.83–1.76) 1.29 (0.88–1.89)
P-trend 0.62 0.64 0.42 0.24
Folate mg/day
Quintile 1c 212 1.00 1.00 1.00
Quintile 2 259 0.71 (0.52–0.96) 0.70 (0.52–0.96) 0.77 (0.52–1.14)
Quintile 3 295 0.75 (0.55–1.02) 0.74 (0.54–1.03) 0.86 (0.51–1.44)
Quintile 4 331 0.49 (0.36–0.68) 0.49 (0.35–0.68) 0.58 (0.32–1.05)
Quintile 5 400 0.70 (0.51–0.95) 0.69 (0.47–0.99) 0.83 (0.39–1.75)
P-trend ,0.0001 ,0.0001 0.03
Vitamin C supplement use
Noc 1.00 1.00 1.00 1.00
Yes 0.90 (0.61–1.33) 0.90 (0.61–1.33) 0.92 (0.61–1.38) 0.93 (0.63–1.38)
P-trend 0.45 0.44 0.54 0.63
Vitamin E supplement use
Noc 1.00 1.00 1.00 1.00
Yes 1.13 (0.68–1.88) 1.13 (0.68–1.87) 1.10 (0.65–1.87) 1.16 (0.70–1.93)
P-trend 0.48 0.48 0.59 0.40
a Adjusted for current smoking, years of smoking cigarettes, number of cigarettes per day, highest educational level, family history of lung cancer, and age.
b SES, socioeconomic status; cat, categories; cont, continuous.
c Reference category.
d Category 1, quintile 1; Category 2, quintiles 2 and 3; Category 3, quintiles 4 and 5.
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association between smoking and intake of several nutrients
was also found in the Netherlands Cohort Study of Diet and
Cancer, although it was not very strong and not very consistent.
For example, never-smokers had higher intakes of all carote-
noids, vitamin C, and folate than former smokers, and current
smokers had the lowest intakes for all food constituents of
interest. To minimize residual confounding attributable to
smoking, we made an attempt to model cigarette smoking
habits such that they best explained lung cancer. This resulted
in a model including number of years smoked, habitual number
of cigarettes smoked per day, both as continuous variables, and
an indicator variable for current smoking. When we added the
smoking variables to an age-adjusted model, the RR estimates
for food constituents and lung cancer changed only slightly
(data not shown). We believe, therefore, that the inverse asso-
ciation observed between the food constituents of interest and
lung cancer was not entirely attributable to residual confound-
ing by smoking, although we cannot exclude some influence.
In this study, adjustment for either vitamin C or folate
intake reduced the effects of carotenoids importantly. This led
to the conclusion that vitamin C and folate might be more
important in terms of protection against lung cancer incidence
than the carotenoids. Using combinations of men high in intake
of both nutrients versus men with a low intake, we could
conclude that the effects of vitamin C and folate are independ-
ent of each other.
In the past decade, five cohort studies have reported RRs
for b-carotene, three showing nonsignificant inverse associa-
tions with lung cancer (14, 15, 19), one a nonsignificant inverse
association for women but no association for men (13), and one
a significant inverse trend only for subjects with stable high
intakes over a 10-year period (16). One cohort study recently
published data on individual dietary carotenoids, showing a
statistically significant inverse association for a-carotene only.
For total carotenoids, significant negative associations have
been found for men only in the New York State Cohort Study
(18) and for nonsmoking men in the Finnish Mobile Clinic
Health Survey (12). Nonsignificant negative associations have
been found in policy holders with the Lutheran Brotherhood
Insurance Society (14) and in the First National Health and
Nutrition Examination Survey Epidemiological Follow-up
Study (17). Two cohort studies have recently reported RRs for
vitamin C of the same magnitude as those we found (RR 0.63
for the highest versus the lowest category; Refs. 17 and 18).
Others found inverse nonsignificant (14, 15) or nonconsistent
(16) RRs for vitamin C, one only found a nonsignificant inverse
association for women but no association for men (13), and one
study found a strong inverse relationship for nonsmokers only
(12). A statistically significant positive association for vitamin
C was found recently in the Nurses’ Health Study (19), but
supplements were included, resulting in much higher intakes in
the highest quintiles than in our study. No data were presented
excluding supplement use. As in our study, no effect was found
for vitamin E in all five studies that included this nutrient (12,
16–19). In our study, among the nutrients included, folate
appeared to be the strongest and most consistent protective
factor against lung cancer incidence. A highly significant in-
verse association for folate was found in the New York State
cohort as well (18), but the Nurses’ Health Study found no
association (19). Again, however, in the latter study, supple-
ments were included. Intake levels of the fourth quintile in the
NHS were comparable with the fifth quintile level in our study
(about 400 mg/day), and the RR of this fourth quintile of the
NHS (compared with the first) was 0.7 (95% CI, 0.5–0.9). A
negative association with folate may be an important finding,
Table 5 RRsa (95% CIs) for quintiles (Q) or tertiles (T) of dietary intake of
carotenoids, vitamins C and E, and folate, among never-smokers, former
smokers, and current smokers: Netherlands Cohort Study 1986–1992
Quintiles/
tertiles
Never-smokersb Former smokersb Current smokersb
Cases: n 5 35 Cases: n 5 312 Cases: n 5 487
Subcohort:
n 5 203
Subcohort:
n 5 728
Subcohort:
n 5 476
a-Carotene
Q/T 1c 1.00 1.00 1.00
Q/T 2 1.32 (0.46–3.79) 0.63 (0.38–1.03) 0.58 (0.38–0.90)
Q/T 3 1.61 (0.61–4.21) 0.53 (0.32–0.88) 0.79 (0.52–1.21)
Q 4 0.74 (0.46–1.19) 0.83 (0.54–1.28)
Q 5 0.96 (0.60–1.56) 0.76 (0.49–1.17)
P-trend 0.27 0.94 0.41
b-Carotene
Q/T 1c 1.00 1.00 1.00
Q/T 2 2.35 (0.83–6.65) 0.62 (0.39–1.00) 0.82 (0.54–1.25)
Q/T 3 1.98 (0.75–5.26) 0.72 (0.44–1.19) 0.83 (0.54–1.27)
Q 4 0.77 (0.48–1.24) 0.79 (0.51–1.24)
Q 5 0.83 (0.51–1.34) 0.74 (0.47–1.16)
P-trend 0.14 0.58 0.05
Lutein/Zeaxanthin
Q/T 1c 1.00 1.00 1.00
Q/T 2 0.83 (0.29–2.35) 0.83 (0.52–1.33) 0.74 (0.49–1.13)
Q/T 3 1.35 (0.56–3.26) 0.59 (0.36–0.96) 0.84 (0.54–1.29)
Q 4 0.88 (0.54–1.44) 0.64 (0.42–0.99)
Q 5 0.66 (0.39–1.09) 0.69 (0.45–1.07)
P-trend 0.42 0.05 0.003
b-Cryptoxantin
Q/T 1c 1.00 1.00 1.00
Q/T 2 0.50 (0.18–1.41) 0.89 (0.55–1.42) 0.69 (0.45–1.05)
Q/T 3 0.86 (0.36–2.06) 0.68 (0.41–1.13) 0.61 (0.40–0.93)
Q 4 0.76 (0.47–1.24) 0.58 (0.37–0.90)
Q 5 1.08 (0.67–1.73) 0.51 (0.33–0.79)
P-trend 0.76 0.98 ,0.0001
Lycopene
Q/T 1c 1.00 1.00 1.00
Q/T 2 0.92 (0.32–2.65) 0.92 (0.57–1.49) 0.72 (0.47–1.09)
Q/T 3 1.54 (0.61–3.90) 1.21 (0.75–1.96) 0.89 (0.58–1.37)
Q 4 0.97 (0.59–1.60) 1.08 (0.71–1.66)
Q 5 1.06 (0.64–1.74) 0.81 (0.53–1.23)
P-trend 0.26 0.68 0.74
Vitamin Cd
Category 1c 1.00 1.00 1.00
Category 2 0.72 (0.26–1.99) 0.75 (0.50–1.12) 0.70 (0.49–1.01)
Category 3 0.67 (0.25–1.79) 0.84 (0.56–1.27) 0.54 (0.38–0.78)
P-trend 0.39 0.38 ,0.0001
Vitamin E
Q/T 1c 1.00 1.00 1.00
Q/T 2 0.80 (0.32–2.02) 1.39 (0.85–2.29) 1.19 (0.78–1.82)
Q/T 3 0.67 (0.26–1.67) 1.06 (0.64–1.76) 1.20 (0.78–1.85)
Q 4 0.98 (0.59–1.64) 1.12 (0.72–1.72)
Q 5 1.19 (0.71–1.98) 0.97 (0.62–1.53)
P-trend 0.32 0.94 0.79
Folate
Q/T 1c 1.00 1.00 1.00
Q/T 2 1.04 (0.39–2.77) 0.72 (0.45–1.15) 0.71 (0.47–1.07)
Q/T 3 1.09 (0.44–2.72) 0.79 (0.50–1.26) 0.75 (0.48–1.16)
Q 4 0.79 (0.49–1.29) 0.37 (0.24–0.58)
Q 5 0.72 (0.45–1.17) 0.63 (0.41–0.98)
P-trend 0.82 0.16 ,0.0001
a Adjusted for highest educational level, family history of lung cancer, and age.
For current smokers and former smokers, also adjusted for years of smoking
cigarettes and number of cigarettes per day (continuous).
b RR (95% CI).
c Reference category.
d Category 1, quintile 1; Category 2, quintiles 2 and 3; Category 3, quintiles
4 and 5.
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because folate possibly has a role in carcinogenesis, given its
involvement in DNA synthesis, methylation, and repair (32).
However, thus far, it has rarely has been associated with the
incidence of lung cancer.
As summarized by Van Poppel and Goldbohm (33), cohort
studies using plasma concentrations of b-carotene have found
remarkably consistent negative associations with lung cancer.
This could be in line with our results, because plasma b-caro-
tene can be considered to be a marker for folate, vitamin C, or
other carotenoids. In a prospective study published recently,
levels of several carotenoids and other antioxidants in blood
were linked to lung cancer risk (34). Protective effects on lung
Table 6 RRsa (95% CI) for quintiles of dietary intake of carotenoids, vitamins C and E, and folate, stratified by histological type of lung cancer: Netherlands Cohort
Study 1986–1992
Small cell carcinoma (157 cases) Squamous cell carcinoma (377 cases) Adenocarcinoma (143 cases)
n RR (95% CI) n RR (95% CI) n RR (95% CI)
a-Carotene
Quintile 1b 47 1.00 95 1.00 25 1.00
Quintile 2 23 0.42 (0.24–0.73) 61 0.56 (0.38–0.82) 30 0.98 (0.55–1.75)
Quintile 3 26 0.55 (0.32–0.93) 64 0.66 (0.45–0.97) 30 1.14 (0.64–2.03)
Quintile 4 36 0.69 (0.42–1.14) 80 0.77 (0.53–1.12) 38 1.41 (0.81–2.44)
Quintile 5 25 0.59 (0.34–1.02) 77 0.93 (0.64–1.35) 20 0.90 (0.48–1.69)
P-trend 0.17 0.83 0.63
b-Carotene
Quintile 1b 41 1.00 96 1.00 21 1.00
Quintile 2 31 0.68 (0.40–1.15) 67 0.63 (0.44–0.93) 35 1.53 (0.85–2.76)
Quintile 3 26 0.63 (0.36–1.09) 72 0.76 (0.52–1.10) 29 1.39 (0.76–2.56)
Quintile 4 32 0.71 (0.42–1.21) 64 0.64 (0.43–0.94) 35 1.72 (0.95–3.11)
Quintile 5 27 0.69 (0.40–1.19) 78 0.88 (0.60–1.27) 23 1.18 (0.62–2.24)
P-trend 0.17 0.37 0.49
Lutein/Zeaxanthin
Quintile 1b 41 1.00 1.00 1.00 33 1.00
Quintile 2 39 1.00 (0.60–1.65) 74 0.76 (0.53–1.10) 20 0.63 (0.34–1.14)
Quintile 3 30 0.80 (0.47–1.35) 72 0.75 (0.52–1.09) 30 0.95 (0.55–1.63)
Quintile 4 20 0.54 (0.30–0.98) 55 0.63 (0.42–0.93) 32 1.12 (0.65–1.91)
Quintile 5 27 0.64 (0.37–1.12) 76 0.75 (0.52–1.08) 28 0.85 (0.49–1.49)
P-trend 0.009 0.03 0.77
b-Cryptoxantin
Quintile 1b 50 1.00 118 1.00 41 1.00
Quintile 2 27 0.66 (0.39–1.12) 71 0.71 (0.49–1.01) 30 0.83 (0.49–1.40)
Quintile 3 23 0.53 (0.30–0.91) 58 0.56 (0.38–0.82) 21 0.55 (0.31–0.97)
Quintile 4 28 0.65 (0.38–1.11) 64 0.62 (0.42–0.90) 20 0.54 (0.30–0.97)
Quintile 5 29 0.61 (0.36–1.04) 66 0.59 (0.41–0.85) 31 0.81 (0.48–1.36)
P-trend 0.04 0.0002 0.12
Lycopene
Quintile 1b 44 1.00 86 1.00 35 1.00
Quintile 2 29 0.72 (0.42–1.22) 80 1.00 (0.69–1.45) 20 0.57 (0.31–1.03)
Quintile 3 28 0.84 (0.49–1.43) 72 1.09 (0.74–1.60) 25 0.86 (0.49–1.51)
Quintile 4 24 0.72 (0.41–1.27) 72 1.10 (0.75–1.61) 35 1.30 (0.77–2.20)
Quintile 5 32 0.86 (0.51–1.45) 67 0.93 (0.63–1.37) 28 0.90 (0.52–1.56)
P-trend 0.54 0.90 0.38
Vitamin Cc
Category 1b 54 1.00 99 1.00 40 1.00
Category 2 46 0.46 (0.30–0.73) 154 0.85 (0.62–1.16) 52 0.68 (0.43–1.07)
Category 3 57 0.54 (0.35–0.83) 124 0.65 (0.47–0.89) 51 0.65 (0.41–1.02)
P-trend 0.003 0.001 0.06
Vitamin E
Quintile 1b 34 1.00 75 1.00 27 1.00
Quintile 2 32 0.99 (0.58–1.70) 87 1.21 (0.83–1.77) 27 1.03 (0.58–1.85)
Quintile 3 31 0.94 (0.55–1.63) 77 1.06 (0.72–1.56) 37 1.40 (0.81–2.42)
Quintile 4 33 0.92 (0.53–1.57) 73 0.96 (0.65–1.41) 26 1.03 (0.58–1.86)
Quintile 5 27 0.83 (0.47–1.47) 65 0.95 (0.64–1.41) 26 1.15 (0.64–2.08)
P-trend 0.45 0.36 0.62
Folate
Quintile 1b 41 1.00 112 1.00 42 1.00
Quintile 2 36 0.88 (0.53–1.47) 72 0.64 (0.44–0.92) 27 0.64 (0.38–1.10)
Quintile 3 31 0.84 (0.49–1.43) 62 0.61 (0.42–0.90) 24 0.63 (0.36–1.09)
Quintile 4 19 0.40 (0.22–0.73) 62 0.51 (0.35–0.74) 27 0.63 (0.37–1.07)
Quintile 5 30 0.74 (0.44–1.27) 69 0.63 (0.44–0.91) 23 0.59 (0.33–1.03)
P-trend 0.02 0.0003 0.04
a Adjusted for current smoking, years of smoking cigarettes, and number of cigarettes per day, highest educational level, family history of lung cancer, and age.
b Reference category.
c Category 1, quintile 1; Category 2, quintiles 2 and 3; Category 3, quintiles 4 and 5.
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cancer were found for b-cryptoxanthin, b-carotene, and lutein
1 zeaxanthin. Nonsignificant protective effects were found for
a-carotene and ascorbic acid. No effect was found for lycopene,
a-tocopherol, and selenium.
Negative associations were strongest among current smok-
ers at baseline and weaker for former smokers. Only 35 cases
were never-smokers, and no significant associations with the
carotenoids and vitamins mentioned could be found. These
results are contradictory to results in Finnish men (117 lung
cancer cases), where inverse gradients were found for summed
carotenoids (a- carotene, b-carotene, g-carotene, lycopene, and
lutein 1 zeaxanthin), vitamin E (nonsignificant), vitamin C,
and lung cancer incidence only in nonsmokers. However, in
that study, nonsmokers included both former smokers (18
cases) and never-smokers (6 cases). Among smokers (93 cases),
no associations were found (12). More in line with our results
are those from the National Health and Nutrition Examination
Survey Epidemiological Follow-up Study, showing a protective
effect of carotenoids and vitamin C only among current smok-
ers, not in nonsmokers (never-smokers 1 former smokers). In
that study, significant inverse associations were found only in
the lowest tertiles of pack-years of smoking for carotenoids,
vitamin C, and vitamin E (17). In the Iowa Women’s Health
Survey, separate analyses were made on b-carotene for current
smokers (81 cases), ex-smokers (38 cases), and never-smokers
(19 cases). Because of the small number of cases, conclusions
were hard to draw, but the association seemed to be stronger in
former than in current smokers (15). In the New York State
Cohort, only analyses have been presented for light and heavy
smokers separately. Risk estimates for vitamin C and carote-
noids were of similar magnitude for light and heavy smokers.
The effect of folate appears to be the strongest in heavy smok-
ers (18). As shown in this study, estimates change after cor-
rection for either vitamin C or folate. Comparisons with other
studies have to be made without further adjustment, because
other groups have not presented adjusted results. In summary,
results of different studies are hard to compare because analyses
were based on different definitions of smoking strata. In gen-
eral, results on never-smokers are not relevant thus far in cohort
studies, because insufficient cases had been diagnosed to do
proper analyses. However, as summarized by Ziegler et al. (4),
case-control studies that focused on never smokers found ef-
fects of carotenoids, vegetables, and fruit similar in magnitude
to those generally observed among active smokers.
In the present study, negative associations with carote-
noids seemed to be limited to small cell carcinomas and squa-
mous cell carcinomas. Both folate and vitamin C intake ap-
peared to be inversely related to small cell, squamous cell, and
adenocarcinomas. Two other cohort studies have presented
results stratified by histological type of lung cancer. The New
York State Cohort Study analyses were performed separately
for squamous cell carcinomas and adenocarcinomas, indicating
significant inverse associations of vitamin C and folate with
squamous cell carcinomas only (18). In the Iowa Women’s
Health Study, analyses on b-carotene were performed sepa-
rately for adenocarcinomas, small cell carcinomas, squamous
cell carcinomas, and large cell carcinomas, revealing only a
(nonsignificant) negative association for small cell carcinomas
(37 cases) and large cell carcinomas (12 cases). Because of the
small numbers of cases, these latter results might be less accu-
rate (15). Results of the New York State Cohort Study are in
line with our results, although it should be stressed that in our
study, additional adjustment for either folate or vitamin C
importantly influenced risk estimates. A lack of effect of caro-
tenoids, vitamin C, and folate on adenocarcinomas might be
attributable to the fact that these are less strongly related to
smoking (18).
By comparing our findings with available results of cohort
studies, we conclude that carotenoids, especially b-carotene,
and vitamin E have only marginal inverse associations with
lung cancer incidence. This is in line with results of the three
major published intervention trials that have not found a reduc-
tion in lung cancer incidence in subjects given vitamin E (35),
vitamin A (36), or b- carotene (35–37). However, our study has
indicated that lutein 1 zeaxanthin and b-cryptoxanthin, as well
as vitamin C and folate, might be more promising food com-
ponents in this matter, although associations with both carote-
noids did not persist after further adjustment with vitamin C or
folate.
Results from this prospective cohort study indicate that
a-carotene and b-carotene appear not to be the food constitu-
ents responsible for a lower lung cancer incidence with higher
vegetable and/or fruit consumption. The role of other important
carotenoids (if any) may be limited to lutein 1 zeaxanthin and
b-cryptoxanthin, and more studies are required to allow definite
conclusions to be drawn. Because both vitamin C and folate
appear to have a stronger protective impact on lung cancer risk,
these should be included in future analyses. It remains possible,
however, that inverse associations with lung cancer risk are a
generalized fruit and vegetable effect and cannot be attributed
to one or more specific nutrients.
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